Despite the large increase in the number of multi-organ transplants (MOTs) performed over the past few years, challenges still exist in this arena. Among these unresolved issues are a lack of standardized MOT eligibility criteria across institutions, regions and different organ combinations. Ethical issues have also arisen regarding equity in organ allocation amidst a limited organ supply, as many MOT candidates get priority allocation for nonprimary organs versus individuals requiring that organ as a single transplant; this prioritization may impact optimal recipient and graft survival as well. In this session, learn more about multi-organ allocation and its accompanying challenges, risks, benefits, and expected outcomes, as well as the limitations of MOT for potential recipients.

In this activity, participants will learn about the timeline for UNOS’s implementation of this flexible, points-based approach for all organ systems; how continuous distribution differs from the current system; and how this program is expected to benefit those who await organ transplant and impact future organ-allocation policy.

Join this activity to discuss how technology to treat end-stage kidney failure has advanced in recent years, including a review of clinical trials of portable devices and implantable xenotransplants, and what the future holds for the next phase of investigation into the artificial kidney and xenotransplant.

This activity will discuss these novel agents’ indications, risks, and benefits and will address which patient populations are most likely to benefit from particular agents. In addition, early-phase clinical trials and emerging therapies will be explored.